Patents by Inventor René Draaisma

René Draaisma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide having an ace inhibiting effect
    Publication number: 20070141120
    Abstract: Use of the tripeptide XPP, wherein X= C, M, S, T, or K, and/or salts thereof for the preparation of an angiotensin-converting enzyme inhibitor and food products comprising the tripeptide XPP.
    Type: Application
    Filed: November 19, 2004
    Publication date: June 21, 2007
    Inventors: Salomon Abrahamse, Rene Draaisma, Johannes Schalk, Christianus Van Platerink
  • Hydrolysed casein product comprising tripeptides ipp and/or vpp
    Publication number: 20070054352
    Abstract: Process for the preparation of a hydrolysed casein product comprising tripeptides VPP, IPP and/or LPP, wherein a substrate comprising casein or casein fragments is subjected to enzyme treatment wherein the enzyme is derived from Aspergillus, wherein the enzyme concentration is 2-10 wt. % based on casein and that the enzyme has a high proteolytic activity.
    Type: Application
    Filed: April 23, 2004
    Publication date: March 8, 2007
    Inventors: Monique van der Burg-Koorevaar, Rene Draaisma, Johannes Schalk
  • Fermented milk product comprising tripeptide vpp and/or ipp
    Publication number: 20060246178
    Abstract: The invention relates to a fermented milk product comprising an amount of tripeptides VPP and/or IPP expressed as equivalent IPP concentration [IPPeq] of 145 ?M or more comprising 40-600 mmol/kg K+ and/or 30-400 mmol/kg Ca2+ and/or 6-50 mmol/kg Mg2+.
    Type: Application
    Filed: December 3, 2003
    Publication date: November 2, 2006
    Inventors: René Draaisma, Mettina Koning, Adrianus Ledeboer, Johannes Schalk
  • Fermented milk product
    Publication number: 20050008751
    Abstract: A Fermented milk product is described having an ACE inhibitory effect of at least 35 U/ml, wherein the milk product is produced from milk fermented with Lactobacillus delbrueckii subsp. lactis. Further a food product is described comprising an amount of 0.003 mg/g protein, or more a peptide or peptide salt having 2-15 amino acids, comprising the peptide sequence Asp-Lys and/or Ile-His-Pro-Phe.
    Type: Application
    Filed: August 3, 2004
    Publication date: January 13, 2005
    Inventors: Rene Draaisma, Mettina Koning, Adrianus Ledeboer, Elisabeth Leigh-Firbank, Christianus Van Platerink, Johannes Schalk
  • Fermented milk product
    Publication number: 20020182301
    Abstract: A Fermented milk product is described having an ACE inhibitory effect of at least 35 U/ml, wherein the milk product is produced from milk fermented with Lactobacillus delbrueckii subsp. lactis. Further a food product is described comprising an amount of 0.003 mg/g protein, or more a peptide or peptide salt having 2-15 amino acids, comprising the peptide sequence Asp-Lys and/or Ile-His-Pro-Phe.
    Type: Application
    Filed: March 8, 2002
    Publication date: December 5, 2002
    Applicant: Unilever Bestfoods North America, Division of Conopco, Inc.
    Inventors: Rene Draaisma, Mettina Maria Koning, Adrianus Marinus Ledeboer, Elisabeth Claire Leigh-Firbank, Christianus Jacobus Van Platerink, Johannes Schalk